5-Methoxy-N,N-Diisopropyltryptamine
Grundinformationen
- CAS
4021-34-5- Standard-SMILES
COc1ccc2[nH]cc(CCN(C(C)C)C(C)C)c2c1- InChIKey
DNBPMBJFRRVTSJ-UHFFFAOYSA-N- Summenformel
- C17H26N2O
- Durchschnittliche Molmasse
- 274,4 g/mol
- Monoisotopische Masse
- 274,20451346
Überblick
5-methoxy-N,N-diisopropyltryptamine is a member of tryptamines. It has a role as a hallucinogen. It is functionally related to a 5-methoxytryptamine and a N,N-diisopropyltryptamine.
Namen und Bezeichner
- Bevorzugter Name
- 5-Methoxy-N,N-Diisopropyltryptamine
- IUPAC
- N-[2-(5-methoxy-1H-indol-3-yl)ethyl]-N-propan-2-ylpropan-2-amine
- Englischer Name
- 5-Methoxy-N,N-diisopropyltryptamine
- Summenformel
- C17H26N2O
- Molmasse
- 274.4
Namen und Synonyme
5-Methoxy-N,N-diisopropyltryptamine4021-34-55-MeO-DIPTFoxy methoxy5-methoxy-N,N-bis(1-methylethyl)-1H-Indole-3-ethanamineDTXSID0019320912D06G8W8ECHEBI:48282N-(1-methylethyl)-N-{2-[5-(methyloxy)-1H-indol-3-yl]ethyl}propan-2-amineN-{2-[5-(methyloxy)-1H-indol-3-yl]ethyl}-N-(propan-2-yl)propan-2-amineN-(1-methylethyl)-N-(2-(5-(methyloxy)-1H-indol-3-yl)ethyl)propan-2-amineN-(2-(5-(methyloxy)-1H-indol-3-yl)ethyl)-N-(propan-2-yl)propan-2-amine
Weitere Namen anzeigen
5-methoxy DiPTAMINOHETEROCYCLIRING5-Methoxy-diisopropyltryptaMine5-MEO-DIPT hydrate hydrochlorideN-diisopropyl-5-methoxy-tryptaminen,n-diisopropyl-5-methoxytrytamine5-methoxy DiPT (exempt preparation)N,N-DIISOPROPYL-5-METHOXYTRYPTAMINE
RefChem:103048DTXCID60115700110-145-21H-Indole-3-ethanamine, 5-methoxy-N,N-bis(1-methylethyl)-N-isopropyl-N-[2-(5-methoxy-1H-indol-3-yl)ethyl]propan-2-amine3-[2-(diisopropylamino)ethyl]-5-methoxyindoleNCGC00247717-013-(2-(DIISOPROPYLAMINO)ETHYL)-5-METHOXYINDOLE
Eigenschaften
Berechnete Struktureigenschaften
- XLogP
- 3,1
- Polarare Oberfläche (TPSA)
- 28,3 Ų
- H-Brücken-Donoren
- 1
- H-Brücken-Akzeptoren
- 2
- Frei drehbare Bindungen
- 6
- Schwere Atome
- 20
- Formalladung
- 0
- Komplexität
- 285
Experimentelle und physikochemische Eigenschaften
Drugs
DEA Schedule I Controlled Substance -> Hallucinogenic substances
Pharmaceuticals -> Listed in ZINC15
Pharmaceuticals -> Synthetic Cannabinoids or Psychoactive Compounds
Physikochemische Eigenschaften
- Schmelzpunkt
- 181 · 181-186 °C
- Siedepunkt
- 411.3 · 411.3±35.0 °C(Predicted)
- Dichte
- 1.032 · 1.032±0.06 g/cm3(Predicted)
- storage temp.
- Room temp
- Löslichkeit
- 5 mg/ml; · DMF: 5 mg/ml; DMSO: 3 mg/ml; Ethanol: 16 mg/ml; Ethanol:PBS (pH 7.2) (1:3): 0.25 mg/ml
- Aggregatzustand
- A crystalline solid
- pka
- 16.93 · 16.93±0.30(Predicted)
- CAS Datenbank
- 4021 · 4021-34-5(CAS DataBase Reference)
Sicherheit und Regulatorisches
Sicherheitsangaben dienen nur zur Orientierung und ersetzen weder das Sicherheitsdatenblatt (SDB) des Lieferanten noch geltende Vorschriften oder eine fachliche Bewertung.
GHS-Klassifizierung
GHS Classification
Warning
H302 (100%): Harmful if swallowed [Warning Acute toxicity, oral]
P264, P270, P301+P317, P330, and P501 (click each P-code to see the statement)
The GHS information provided by 1 company from 1 notification to the ECHA C&L Inventory.
Gefahrenhinweise
Regulatory InformationDEA schedule I controlled substance
Hazard Classes and CategoriesAcute Tox. 4 (100%)
Sicherheitsdaten
- risk_code
- 36/37/38
- hazard_code
- Xi
- safety_code
- 26
- DEA Controlled Substances
- CSCN: 7439CSA SCH: Schedule INARC: No
Chemie und Industrie
Pharmakologische Informationen
Pharmacodynamics
5-methoxy-diisopropyltryptamine, also known as 5-methoxy-N,N-diisopropyltryptamine, 5-MeO-DiPT, foxy methoxy, or just foxy, is a tryptamine that is used recreationally as a psychedelic. 5-MeO-DiPT is orally active, and dosages between 6–20 mg are commonly reported. Many users note an unpleasant body load accompanies higher dosages. 5-MeO-DiPT is also taken by insufflation, or sometimes it is smoked or injected. Some users also report sound distortion, also noted with the related drug, DiPT.
Metabolism/Metabolites5-Methoxy-N,N-diisopropyltryptamine has known human metabolites that include 5-MeO-IPT and 5-hydroxy-DIPT.
Absorption, Distribution and Excretion5-MeO-DIPT produces effects with an onset of 20 to 30 minutes and with peak effects occurring between 1 to 1.5 hours after administration.
Anbieter
Wird geladen…
Öffentliche Anfragen
Wird geladen…
Zugehörige Reaktionen
0
Keine Reaktionsaufzeichnungen unter den aktuellen Filterkriterien.
Notizen zur Verbindung
Wird geladen…